Overall, these findings suggest that RBP4, through the TLR4-mediated signaling pathway, not only directly impair GLUT4 expression in cardiomyocytes but also promote expression of pro-inflammatory cytokines and cardiac hypertrophy (75). The gene discussed is RBP4; the disease is cardiac hypertrophy.